Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomized controlled trials. BMJ 317:235–240CrossRefGoogle Scholar

Finfer S, Bellomo R, Boyce N et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350:2247–2256PubMedCrossRefGoogle Scholar

Dubois MJ, Orellana-Jimenez C, Melot C et al (2006) Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 34:2536–2540PubMedCrossRefGoogle Scholar

Vincent JL, Sakr Y, Reinhart K et al (2005) Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit care 9:R745–R754PubMedCrossRefPubMedCentralGoogle Scholar

Schortgen F, Girou E, Deye N et al (2008) The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 34:2157–2168PubMedCrossRefGoogle Scholar

Charpentier J, Mira J-P (2011) Efficacy and tolerance of hyperoncotic albumin administration in septic shock patients: the EARSS study. Intensive Care Med 37(Suppl 1):115Google Scholar

Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412–1421PubMedCrossRefGoogle Scholar

Wiedermann CJ, Joannidis M (2014) Albumin replacement in severe sepsis or septic shock. N Engl J Med 371:83PubMedCrossRefGoogle Scholar

Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med 41:580–637PubMedCrossRefGoogle Scholar